Advisor Group Holdings, Inc. Bluebird Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.2 Billion
  • Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 16,510 shares of BLUE stock, worth $5,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,510
Previous 18,325 9.9%
Holding current value
$5,778
Previous $17,000 52.94%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.47 - $1.35 $853 - $2,450
-1,815 Reduced 9.9%
16,510 $8,000
Q2 2024

Aug 13, 2024
SELL
$0.85 - $1.26 $26,236 - $38,892
-30,867 Reduced 62.75%
18,325 $17,000
Q1 2024

May 10, 2024
SELL
$0.91 - $1.75 $1,458 - $2,805
-1,603 Reduced 3.16%
49,192 $62,000
Q4 2023

Feb 12, 2024
BUY
$1.32 - $4.83 $20,973 - $76,743
15,889 Added 45.52%
50,795 $70,000
Q3 2023

Nov 13, 2023
BUY
$3.02 - $4.05 $21,318 - $28,588
7,059 Added 25.35%
34,906 $106,000
Q2 2023

Aug 21, 2023
SELL
$2.79 - $5.03 $128 - $231
-46 Reduced 0.16%
27,847 $91,000
Q2 2023

Aug 10, 2023
SELL
$2.79 - $5.03 $3,733 - $6,730
-1,338 Reduced 4.58%
27,893 $91,000
Q1 2023

May 12, 2023
SELL
$3.14 - $8.22 $96,875 - $253,603
-30,852 Reduced 51.35%
29,231 $92,000
Q4 2022

Feb 10, 2023
BUY
$5.77 - $8.49 $218,538 - $321,558
37,875 Added 170.55%
60,083 $415,000
Q3 2022

Nov 14, 2022
BUY
$3.75 - $7.39 $3,078 - $6,067
821 Added 3.84%
22,208 $140,000
Q2 2022

Aug 10, 2022
SELL
$2.94 - $5.23 $849 - $1,511
-289 Reduced 1.33%
21,387 $89,000
Q1 2022

May 04, 2022
BUY
$4.07 - $10.6 $29,145 - $75,906
7,161 Added 49.34%
21,676 $1.87 Million
Q3 2021

Nov 05, 2021
BUY
$11.24 - $21.0 $25,391 - $47,439
2,259 Added 18.43%
14,515 $277,000
Q2 2021

Aug 02, 2021
BUY
$18.04 - $22.09 $8,623 - $10,559
478 Added 4.06%
12,256 $391,000
Q1 2021

May 13, 2021
BUY
$16.59 - $33.89 $13,255 - $27,078
799 Added 7.28%
11,778 $356,000
Q4 2020

Feb 10, 2021
BUY
$27.5 - $37.92 $13,090 - $18,049
476 Added 4.53%
10,979 $475,000
Q3 2020

Nov 12, 2020
BUY
$34.44 - $43.75 $68,294 - $86,756
1,983 Added 23.27%
10,503 $558,000
Q2 2020

Aug 14, 2020
BUY
$27.12 - $45.97 $6,020 - $10,205
222 Added 2.68%
8,520 $525,000
Q1 2020

May 18, 2020
BUY
$26.16 - $63.5 $217,075 - $526,923
8,298 New
8,298 $383,000

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email